Connected diagnostics to improve accurate diagnosis, treatment, and conditional payment of malaria services in Kenya.
Conditional payments
Connected diagnostics
Diagnosis
Kenya
Malaria
Treatment
Journal
BMC medical informatics and decision making
ISSN: 1472-6947
Titre abrégé: BMC Med Inform Decis Mak
Pays: England
ID NLM: 101088682
Informations de publication
Date de publication:
04 08 2021
04 08 2021
Historique:
received:
18
06
2020
accepted:
29
07
2021
entrez:
5
8
2021
pubmed:
6
8
2021
medline:
10
8
2021
Statut:
epublish
Résumé
In sub-Saharan Africa, the material and human capacity to diagnose patients reporting with fever to healthcare providers is largely insufficient. Febrile patients are typically treated presumptively with antimalarials and/or antibiotics. Such over-prescription can lead to drug resistance and involves unnecessary costs to the health system. International funding for malaria is currently not sufficient to control malaria. Transition to domestic funding is challenged by UHC efforts and recent COVID-19 outbreak. Herewith we present a digital approach to improve efficiencies in diagnosis and treatment of malaria in endemic Kisumu, Kenya: Connected Diagnostics. The objective of this study is to evaluate the feasibility, user experience and clinical performance of this approach in Kisumu. Our intervention was performed Oct 2017-Dec 2018 across five private providers in Kisumu. Patients were enrolled on M-TIBA platform, diagnostic test results digitized, and only positive patients were digitally entitled to malaria treatment. Data on socio-demographics, healthcare transactions and medical outcomes were analysed using standard descriptive quantitative statistics. Provider perspectives were gathered by 19 semi-structured interviews. In total 11,689 febrile patients were digitally tested through five private providers. Malaria positivity ranged from 7.4 to 30.2% between providers, significantly more amongst the poor (p < 0.05). Prescription of antimalarials was substantially aberrant from National Guidelines, with 28% over-prescription (4.6-63.3% per provider) and prescription of branded versus generic antimalarials differing amongst facilities and correlating with the socioeconomic status of clients. Challenges were encountered transitioning from microscopy to RDT. We provide full proof-of-concept of innovative Connected Diagnostics to use digitized malaria diagnostics to earmark digital entitlements for correct malaria treatment of patients. This approach has large cost-saving and quality improvement potential.
Sections du résumé
BACKGROUND
In sub-Saharan Africa, the material and human capacity to diagnose patients reporting with fever to healthcare providers is largely insufficient. Febrile patients are typically treated presumptively with antimalarials and/or antibiotics. Such over-prescription can lead to drug resistance and involves unnecessary costs to the health system. International funding for malaria is currently not sufficient to control malaria. Transition to domestic funding is challenged by UHC efforts and recent COVID-19 outbreak. Herewith we present a digital approach to improve efficiencies in diagnosis and treatment of malaria in endemic Kisumu, Kenya: Connected Diagnostics. The objective of this study is to evaluate the feasibility, user experience and clinical performance of this approach in Kisumu.
METHODS
Our intervention was performed Oct 2017-Dec 2018 across five private providers in Kisumu. Patients were enrolled on M-TIBA platform, diagnostic test results digitized, and only positive patients were digitally entitled to malaria treatment. Data on socio-demographics, healthcare transactions and medical outcomes were analysed using standard descriptive quantitative statistics. Provider perspectives were gathered by 19 semi-structured interviews.
RESULTS
In total 11,689 febrile patients were digitally tested through five private providers. Malaria positivity ranged from 7.4 to 30.2% between providers, significantly more amongst the poor (p < 0.05). Prescription of antimalarials was substantially aberrant from National Guidelines, with 28% over-prescription (4.6-63.3% per provider) and prescription of branded versus generic antimalarials differing amongst facilities and correlating with the socioeconomic status of clients. Challenges were encountered transitioning from microscopy to RDT.
CONCLUSION
We provide full proof-of-concept of innovative Connected Diagnostics to use digitized malaria diagnostics to earmark digital entitlements for correct malaria treatment of patients. This approach has large cost-saving and quality improvement potential.
Identifiants
pubmed: 34348696
doi: 10.1186/s12911-021-01600-z
pii: 10.1186/s12911-021-01600-z
pmc: PMC8335459
doi:
Substances chimiques
Antimalarials
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
233Informations de copyright
© 2021. The Author(s).
Références
PLoS One. 2019 Sep 26;14(9):e0222651
pubmed: 31557170
Malar J. 2015 Jul 08;14:263
pubmed: 26152272
Am J Clin Pathol. 2014 Jun;141(6):791-5
pubmed: 24838322
BMJ Glob Health. 2017 May 16;2(2):e000176
pubmed: 29242750
Malar J. 2016 Nov 14;15(1):555
pubmed: 27842555
Lancet. 2020 Apr 4;395(10230):1094-1096
pubmed: 32192582
Trop Med Int Health. 2015 Dec;20(12):1685-95
pubmed: 26338026
Expert Rev Pharmacoecon Outcomes Res. 2016 Oct;16(5):639-650
pubmed: 26567041
PLoS Med. 2009 Jan 6;6(1):e252
pubmed: 19127974
Malar J. 2018 Apr 16;17(1):166
pubmed: 29661245
Am J Trop Med Hyg. 2009 Mar;80(3):470-4
pubmed: 19270300
BMC Health Serv Res. 2012 Sep 03;12:297
pubmed: 22943592
Malar J. 2017 Dec 21;16(1):494
pubmed: 29268789
BMC Med Inform Decis Mak. 2019 Jul 22;19(1):139
pubmed: 31331394
Annu Int Conf IEEE Eng Med Biol Soc. 2009;2009:1730-3
pubmed: 19964260
Malar J. 2016 Mar 22;15:179
pubmed: 27006074
PLoS One. 2013;8(2):e54305
pubmed: 23418427
N Engl J Med. 2014 Feb 27;370(9):809-17
pubmed: 24571753
Malar J. 2008 Feb 18;7:33
pubmed: 18282270
Trop Med Int Health. 2001 Feb;6(2):99-101
pubmed: 11251904